Beam Therapeutics Inc.
BEAM
$28.79
$2.057.65%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 55.70M | 60.27M | 63.58M | 63.52M | 349.64M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 55.70M | 60.27M | 63.58M | 63.52M | 349.64M |
| Cost of Revenue | 411.79M | 396.28M | 381.56M | 367.56M | 406.19M |
| Gross Profit | -356.09M | -336.00M | -317.98M | -304.04M | -56.55M |
| SG&A Expenses | 110.20M | 109.97M | 112.74M | 111.53M | 126.12M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 521.99M | 506.25M | 494.30M | 479.09M | 532.32M |
| Operating Income | -466.29M | -445.98M | -430.72M | -415.57M | -182.67M |
| Income Before Tax | -414.64M | -398.58M | -387.30M | -376.70M | -142.19M |
| Income Tax Expenses | 0.00 | 0.00 | 39.00K | 39.00K | 1.41M |
| Earnings from Continuing Operations | -414.64 | -398.58 | -387.34 | -376.74 | -143.59 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -414.64M | -398.58M | -387.34M | -376.74M | -143.59M |
| EBIT | -466.29M | -445.98M | -430.72M | -415.57M | -182.67M |
| EBITDA | -444.22M | -423.99M | -408.70M | -393.64M | -160.83M |
| EPS Basic | -4.43 | -4.51 | -4.61 | -4.58 | -1.72 |
| Normalized Basic EPS | -2.81 | -2.81 | -2.80 | -2.77 | -0.99 |
| EPS Diluted | -4.44 | -4.51 | -4.62 | -4.58 | -1.76 |
| Normalized Diluted EPS | -2.81 | -2.81 | -2.80 | -2.77 | -1.01 |
| Average Basic Shares Outstanding | 375.37M | 355.20M | 335.52M | 329.25M | 327.28M |
| Average Diluted Shares Outstanding | 375.37M | 355.20M | 335.52M | 329.25M | 329.12M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |